NCT00461578View on ClinicalTrials.gov

Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children

NACompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

October 31, 2006

Conditions

Malaria

Interventions

DRUG

Chlorproguanil-dapsone + artesunate

Trial Locations (1)

BP 2514

Programme Nationale Integre de Lutte contre le Paludisme, Kigali

All Listed Sponsors

collaborator

Institute of Tropical Medicine, Belgium

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00461578 - Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan Children | Biotech Hunter | Biotech Hunter